The News Review:
- A spotlight on the professions
- Howard Feldman Joins Bristol-Myers Squibb as Vice President and …
- Vicor Technologies CE David Fater Discusses Company’s Diagnostics …
A spotlight on the professions
Boston Globe United States
Clinical Research pen House. Program will introduce course offerings roles within clinical research and job opportunities. Meets from 6 to 8 p.
Howard Feldman Joins Bristol-Myers Squibb as Vice President and …
MarketWatch (press release)
Howard Feldman has joined the company’s Research and Development organization as vice president and therapeutic area head Global Clinical Research Neuroscience. He will report to Dr. Doug Manion vice president Global Clinical Research Neuroscience and Virology. “I am pleased Howard has joined our R&D organization as we look to further build our robust pipeline in areas of significant unmet medical need in neuroscience” said Brian Daniels M. Senior Vice President Global Development & Medical Affairs.
Related from Marketingmonster: Entropic Communications Adds Senior Vice President of Marketing …
Vicor Technologies CE David Fater Discusses Company’s Diagnostics …
CNNMoney.com
The PD2i CA (Cardiac Analyzer) in a multi-sitemulti-year trial (the VITAL Trial) being conducted by the Harvard ClinicalResearch Institute identifies patients at risk of suffering sudden cardiacdeath. Vicor anticipates additional applications employing the PD2i to enableearly detection and risk stratification for a variety of other disordersand diseases. Additional information is available at.
